Summary
Apexigen Inc
Description
Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.
Strengths
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- Since Apexigen Inc was founded, the company has grown faster than the industry average
Weaknesses
- Apexigen Inc has a very small market share in their industry
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Apexigen Inc's annual revenue
$4227000
Based on Kona Equity data
-
Revenue per employee
$301929
-
Variance of revenue growth
4.57
-
Annual revenue growth since founding
$301928
-
Revenue growth rate from first known quarter to current
136.3%
Employee Count
20 employees
-
Employee growth rate from first known quarter to current
53.3%
Executives
Amy Wong
Vice President, Finance
a**@apexigen.comGeorge Huang
Senior Scientist, Head of Antibody Discovery
g**@apexigen.comAnne Moustache
Executive Assistant To
a**@apexigen.comSarah Chiu
Director, Finance
s**@apexigen.comMonique Devine
Manager, Accounting
m**@apexigen.comRandy Beyea
Director, Quality Assurance
r**@apexigen.comWilliam Duke
Chief Financial Officer
w**@apexigen.comLinda Rubinstein
Interim Chief Financial Officer
l**@apexigen.comYongke Zhang
Director, Preclinical Development & Clinical Research
y**@apexigen.comFrancis Sarena
Chief Operating Officer
f**@apexigen.comVlad Zomborean
Clinical Trial Associate
v**@apexigen.comJamie Grayson
Senior Director, Project Management
j**@apexigen.comXiaodong Yang
CEO
x**@apexigen.comRyan Alvarado
Senior Research Associate
r**@apexigen.comDebbie Cote
Head Executive Director, Clinical Operations
d**@apexigen.comCandy Hong
Controller
c**@apexigen.comSophie Papalia
Senior Director, Regulatory Affairs
s**@apexigen.comLee Shuman
Director, Clinical Development
l**@apexigen.comSusan Owen
Head Senior Director, Clinical Operations
s**@apexigen.comErica Mccluskey
Senior Manager, Clinical Trial
e**@apexigen.comPhone Apexigen
President & Chief Executive Officer
p**@apexigen.comAndrew Lam
Associate Scientist
a**@apexigen.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Apexigen Inc
- Category: Pharmaceuticals
- Industry: Pharmaceutical Company
- SIC: 28; 283
- NAICS: 32541; 5417
See similar companies
-
By City San Carlos Small Pharmaceutical Company in San Carlos Mid-size Pharmaceutical Company in San Carlos Pharmaceuticals in San Carlos Small Pharmaceuticals in San Carlos Mid-size Pharmaceuticals in San Carlos
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Pharmaceutical Company in CA Mid-size Pharmaceutical Company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Pharmaceuticals and Pharmaceutical Company
-
Firmographic data G Score of 3 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 5417 #Drug Manufacturing & Research #Hospitals & Clinics #Medical Testing & Clinical Laboratories #Pharmaceuticals #Healthcare
Frequently Asked Questions
Apexigen Inc's headquarters are located at 75 Shoreway Rd. Ste. C San Carlos, CA 94070.
Apexigen Inc's official website is apexigen.com
Apexigen Inc's annual revenue is $4.2 M.
Apexigen Inc's SIC: 28; 283
Apexigen Inc's NAICS: 32541; 5417.
Apexigen Inc has 20 employees
Apexigen Inc is in the industry of Pharmaceuticals.